Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Plans
On May 7, 2024 , Gérard Ber , a member of our Board , entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 15,500 shares of our common stock between September 11, 2024 and April 11, 2025 .
On May 21, 2024 , James Thrall , a member of our Board , entered into a 10b5-1 Plan providing for the potential sale of up to 2,000 shares of our common stock between August 21, 2024 and January 15, 2025 .
45
Table of Contents
Item 6. Exhibits
INCORPORATED BY REFERENCE
EXHIBIT
NUMBER DESCRIPTION OF EXHIBITS FORM FILE
NUMBER EXHIBIT FILING
DATE
10.1 Seventh Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan
8-K 001-36569 10.1 April 29, 2024
10.2*+†† Consulting Agreement by and between Lantheus Medical Imaging, Inc. and Etienne Montagut, effective as of June 7, 2024
31.1* Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a).
31.2* Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).
32.1** Certification pursuant to 18 U.S.C. Section 1350.
101.INS* Inline XBRL Instance Document
101.SCH* Inline XBRL Taxonomy Extension Schema Document
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
104* Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Filed herewith.
** Furnished herewith.
+ Indicates management contract or compensatory plan or arrangement.
†† Portions of this exhibit have been omitted for confidential treatment pursuant to Item 601(b)(10)(iv) of Regulation S-K.
46
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LANTHEUS HOLDINGS, INC.
By: /s/ BRIAN MARKISON
Name: Brian Markison
Title: Chief Executive Officer
(Principal Executive Officer)
Date: July 31, 2024
LANTHEUS HOLDINGS, INC.
By: /s/ ROBERT J. MARSHALL, JR.
Name: Robert J. Marshall, Jr.
Title: Chief Financial Officer and Treasurer
(Principal Financial Officer)
Date: July 31, 2024
47
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.